Question 6
The patient needs to take the recommendations in question 5 or he likely has a very dim future if his BP and cholesterol is not lowered a lot. Blood pressure should be measured after the patient has rested for at least five minutes. He should be instructed in advance of the appointment what not to eat or drink so that the test result is not improperly influenced (e.g. drinking caffeine).
Question 7
There is no advancement or progression in symptoms but blood pressure is still entirely too high. It needs to drop by at least 30 points to be within a non-hypertension range. Needs to be made clear to patient that while he is feeling fine for now, that will change if the proper lifestyle changes are not made.
Question 8
A full batter of blood work should be done to get the full picture of what is really going in with the patient. A urinalysis should also be done because that could be instructive as well.
Question 9
The cholesterol is indeed out of whack. The good amount is too low and the bad amount is too high. The QRS voltage is an indicator of LVH and is likely a precursor or symptom of heart issues based on family history and the totality of the symptoms.
Question 10
The lifestyle changes named earlier are now urgent and the patient should be monitored for blockages in arteries as well as heart scans/analysis to find out what, if anything, is systemically or physically wrong with the function and structure of the heart.
2. Chapter 4: Heart Failure
Question 1
There are multiple symptoms in play here that are indicative of congestive heart failure. Specifically, the swelling in the hands and feet, the consistent shortness of breath, the patient's age and the fatigue he is having.
Question 2
The edema in the feet and...
Echocardiogram is another important non-invasive diagnostic tool for AF. This test uses sound waves to produces an image of the heart and helps the cardiologist observe the different regions of the heart and assess their performance. [NIH] Treatment for AF involves different approaches and may also be decided by the cardiologist depending on the nature of the AF. Paroxysmal AF, which lasts for a short duration (maximum few days) is
After ICI discharge daily ECG or predischarge (Jansen et al., 1986; Evrard et al., 2000) Holter monitoring was used to detect arrhythmias. In some cases the monitoring may be continued beyond the hospital stay for 30 (Guarnieri et al., 1999) up to 90 days (Weber et al., 1990). The use of the Holter monitor makes extended monitoring more feasible than when ECG was the only option. Several anomalies have been
Lessening the Incidence of Postoperative Atrial Fibrillation The issue of reducing or preventing atrial fibrillation (AF) after cardiac surgery has been the subject of numerous studies. Existing studies sought to establish which agents are effective in this process since multiple agents are used to prevent AF. Reduction of incidence of postoperative atrial fibrillation is critical in order to promote the outcomes of patients undergoing cardiac surgery. In addition to flutter, atrial
Atrial Fibrillation Simply stated, atrial fibrillation describes a condition in which the human heart beats at an excessively rapid rate that can result in diminished blood flow to the body. While the condition is not typically life-threatening, atrial fibrillation still requires immediate medical care because left untreated, the condition can result in adverse, long-term complications. To determine the facts, this paper reviews the relevant literature concerning the etiology and pathogenesis
Nursing Diagnosis Care Plan Assessment Data Analysis a) Patient is a 65-year-old male Mexican-born retired bus driver with a relevant past medical history of atrial fibrillation and deep vein thrombosis treated with Coumadin who presents with hematuria. Patient sought care after witnessing blood in his urine and feeling generally weak. In addition, the patient has history of hypertension, stroke, DVT, BPH, gout, depression, anxiety, chronic bronchitis and a remote history of chicken
Efficacy and Safety of Dabigatran vs. Warfarin for Stroke After more than five decades as the preferred anticoagulant worldwide, warfarin is being challenged by a new rival that doesn't require careful dosage monitoring. Pradaxa (dabigatran) was unanimously approved by the FDA on October 19, 2010 for treating atrial fibrillation (AF) patients, who are at an increased risk for suffering stroke and systemic embolisms (U.S. Food and Drug Administration). Dabigatran acts by
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now